# Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

> **NCT00532168** · PHASE4 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 108 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** tenofovir + emtricitabine + efavirenz
- **DRUG:** tenofovir + emtricitabine + lopinavir-ritonavir
- **DRUG:** tenofovir + emtricitabine + atazanavir-ritonavir

## Key facts

- **NCT ID:** NCT00532168
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2013-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532168, "Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00532168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*